271 related articles for article (PubMed ID: 23963627)
1. Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.
Ge W; Wang HL; Sun RP
Eur J Pediatr; 2014 Feb; 173(2):213-8. PubMed ID: 23963627
[TBL] [Abstract][Full Text] [Related]
2. Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications.
Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z
Int Immunopharmacol; 2016 Oct; 39():246-250. PubMed ID: 27497193
[TBL] [Abstract][Full Text] [Related]
3. Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
Wang J; Ying Q; Zhong S; Chen Y; Di Y; Dai X; Zheng J; Shen M
Pediatr Neonatol; 2018 Jun; 59(3):238-243. PubMed ID: 28919104
[TBL] [Abstract][Full Text] [Related]
4. Could serum pentraxin 3 levels and IgM deposition in skin biopsies predict subsequent renal involvement in children with Henoch-Schönlein purpura?
Yüksel S; Çağlar M; Evrengül H; Becerir T; Tepeli E; Ergin A; Çiçek EA; Aybek H; Yalçın N; Demirkan NÇ
Pediatr Nephrol; 2015 Jun; 30(6):969-74. PubMed ID: 25543194
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children.
Mao S; Xuan X; Sha Y; Zhao S; Zhu C; Zhang A; Huang S
Int J Clin Exp Pathol; 2015; 8(3):2334-42. PubMed ID: 26045740
[TBL] [Abstract][Full Text] [Related]
6. [Value of galactose-deficient IgA1 in the early diagnosis of Henoch-Schönlein purpura nephritis in children].
Kang ZJ; Liu B; Li ZH; Duan CR; Wu TH; Xun M; Zhang Y; Ding YF; Fu RQ
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):172-175. PubMed ID: 30782282
[TBL] [Abstract][Full Text] [Related]
7. The relationship between red cell distribution width and the risk of Henoch-Schönlein purpura nephritis.
Zhu X; Zhang M; Lan F; Wei H; He Q; Li S; Qin X
Br J Biomed Sci; 2018 Jan; 75(1):30-35. PubMed ID: 28990845
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
10. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
Calvo-Río V; Loricera J; Martín L; Ortiz-Sanjuán F; Alvarez L; González-Vela MC; González-Lamuño D; Mata C; Gortázar P; Rueda-Gotor J; Arias M; Peiró E; Martínez-Taboada VM; González-Gay MA; Blanco R
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S45-51. PubMed ID: 23663681
[TBL] [Abstract][Full Text] [Related]
11. Urinary Macrophage Migration Inhibitory Factor as a Noninvasive Biomarker in Pediatric Henoch-Schönlein Purpura Nephritis.
Wang J; Li Y; Chen Y; Dai X; Di Y; Shen M; Ying Q; Fu S; Li Y
J Clin Rheumatol; 2017 Aug; 23(5):258-261. PubMed ID: 28700526
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
Purevdorj N; Mu Y; Gu Y; Zheng F; Wang R; Yu J; Sun X
Clin Biochem; 2018 Feb; 52():167-170. PubMed ID: 29129626
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
[TBL] [Abstract][Full Text] [Related]
14. Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
Liu L; Liu H; Zhu K; Zhang L; Yin X; Han L; Wang M; Gao S; Xiao X; Yang J; Huang C; Huang Y
J Proteomics; 2023 Mar; 276():104841. PubMed ID: 36796721
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch-Schonlein purpura nephritis.
Zhang L; Han C; Sun C; Meng H; Ye F; Na S; Chen F; Zhang D; Jin X
Transl Res; 2013 Jan; 161(1):26-36. PubMed ID: 23041443
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between leukotrienes and clinical, pathological features of Henoch-Schoenlein purpura nephritis in children].
Chen XY; Yi ZW; He QN
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):272-5. PubMed ID: 19099729
[TBL] [Abstract][Full Text] [Related]
17. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity.
Fengyong Z; Zhixiang F; Jiajia P; Qin L; Min Q; Guoliang W; Ziyan Z
Immunol Lett; 2022 Oct; 250():23-28. PubMed ID: 36174770
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.
Kawasaki Y
Clin Exp Nephrol; 2011 Oct; 15(5):648-657. PubMed ID: 21695413
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.
Zhang J; Zeng H; Wang N; Tian X; Dou W; Shi P
Eur J Pediatr; 2016 Jan; 175(1):49-55. PubMed ID: 26220440
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.
Teng X; Wang Y; Lin N; Sun M; Wu J
Clin Rheumatol; 2016 Mar; 35(3):667-71. PubMed ID: 25273597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
